Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 37596321
Qiao X, et al. (2023) FBXO28 suppresses liver cancer invasion and metastasis by promoting PKA-dependent SNAI2 degradation. Oncogene 42, 2878-2891 37596321
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Information from this record has been curated, but not yet edited in PhosphoSitePlus® and may be incomplete.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

S158-p - Snail2 (human)
Modsite: CDAQSRKsFSCKYCD SwissProt Entrez-Gene
Orthologous residues
Snail2 (human): S158‑p, Snail2 (mouse): S159‑p, Snail2 (rat): S158‑p
Characterization
Methods used to characterize site in vivo mutation of modification site
Disease tissue studied:  liver cancer, hepatocellular carcinoma
Relevant cell lines - cell types - tissues:  HCCLM3 (hepatic), Huh7 (hepatic)
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE PKACA (human) pharmacological inhibitor of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
H-89 decrease
KT5720 decrease
Downstream Regulation
Effect of modification (function):  molecular association, regulation, protein degradation, ubiquitination
Effect of modification (process):  carcinogenesis, inhibited, cell motility, inhibited
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
FBXO28 (human) Induces microscopy-colocalization, co-immunoprecipitation

S247-p - Snail2 (human)
Modsite: KYQCKNCsKTFsRMs SwissProt Entrez-Gene
Orthologous residues
Snail2 (human): S247‑p, Snail2 (mouse): S248‑p, Snail2 (rat): S247‑p
Characterization
Methods used to characterize site in vivo mutation of modification site
Disease tissue studied:  liver cancer, hepatocellular carcinoma
Relevant cell lines - cell types - tissues:  HCCLM3 (hepatic), Huh7 (hepatic)
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE PKACA (human) pharmacological inhibitor of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
H-89 decrease
KT5720 decrease
Downstream Regulation
Effect of modification (function):  molecular association, regulation, protein degradation, ubiquitination
Effect of modification (process):  carcinogenesis, inhibited, cell motility, inhibited
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
FBXO28 (human) Induces carcinogenesis, inhibited, cell motility, inhibited microscopy-colocalization, co-immunoprecipitation

S254-p - Snail2 (human)
Modsite: sKTFsRMsLLHKHEE SwissProt Entrez-Gene
Orthologous residues
Snail2 (human): S254‑p, Snail2 (mouse): S255‑p, Snail2 (rat): S254‑p
Characterization
Methods used to characterize site in vivo mutation of modification site
Disease tissue studied:  liver cancer, hepatocellular carcinoma
Relevant cell lines - cell types - tissues:  HCCLM3 (hepatic), Huh7 (hepatic)
Cellular systems studied:  cell lines
Species studied:  human
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
KINASE PKACA (human) pharmacological inhibitor of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
H-89 decrease
KT5720 decrease
Downstream Regulation
Effect of modification (function):  molecular association, regulation, protein degradation, ubiquitination
Effect of modification (process):  carcinogenesis, inhibited, cell motility, inhibited
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
FBXO28 (human) Induces microscopy-colocalization, co-immunoprecipitation